Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,400 | $1,053 | $1,233 | $1,266 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Cost of Goods Sold | $647 | $502 | $462 | $460 |
| Gross Profit | $753 | $551 | $771 | $806 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| R&D Expenses | $84 | $97 | $169 | $244 |
| G&A Expenses | $195 | $189 | $198 | $297 |
| SG&A Expenses | $583 | $493 | $545 | $664 |
| Sales & Mktg Exp. | $387 | $304 | $346 | $366 |
| Other Operating Expenses | -$26 | -$82 | -$19 | -$18 |
| Operating Expenses | $640 | $508 | $694 | $889 |
| Operating Income | $113 | $44 | $123 | -$1 |
| % Margin | 8.1% | 4.1% | 10% | -0.1% |
| Other Income/Exp. Net | -$15 | -$13 | -$9 | -$9 |
| Pre-Tax Income | $98 | $31 | $68 | $1,969 |
| Tax Expense | $30 | $11 | $22 | $9 |
| Net Income | $93 | $17 | $51 | $1,987 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS | 0.16 | 0.028 | 0.087 | 3.38 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| Weighted Avg Shares Out | 589 | 589 | 589 | 589 |
| Weighted Avg Shares Out Dil | 589 | 589 | 589 | 589 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $6 |
| Interest Expense | $14 | $12 | $7 | $4 |
| Depreciation & Amortization | $148 | $150 | $152 | $147 |
| EBITDA | $260 | $192 | $229 | $2,125 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |